Eli Lilly's Newly FDA-Approved Eczema Drug Improves Skin And Itch In Patients Previously Treated With Sanofi/Regeneron's Dupixent

Benzinga01:57

Sanofi (SNY) Q3 2024 Earnings Call Transcript Summary

Futu News01:48 · Conference Call

Sanofi (SNY) Q3 2024 Earnings Call Transcript

Earnings Call Transcripts01:36

Sanofi Reports Strong Q3 Growth and Raises EPS Guidance

TipRanks00:57

6-K: Report of foreign private issuer (related to financial reporting)

SEC00:42 · Announcements

Sanofi Shocks the Market: Massive Q3 Surge, Game-Changing Moves, and Bold Divestment Plans

Yahoo Finance00:21